MedPath

Study of narayana taila nasya in no menses, painful menses, infrequent menses

Phase 1
Conditions
Health Condition 1: E35- Disorders of endocrine glands in diseases classified elsewhere
Registration Number
CTRI/2022/10/046150
Lead Sponsor
Department of Panchakarma Gurukul campus UAU Haridwar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with signs and symptoms of vataj artava dusti such as vikrit artava varna, ruja and artava which is ruksh, tanu, fenil, alpa, vichinna and vilambit.

2.Patients with polycystic ovaries.

3.Patients having altered FSH/LH.

4.Patients with oligomenorrhoea, dysmenorrhoea, hypomenorrhea and amenorrhoea.

Exclusion Criteria

1.Patients with haemoglobin less than 7 g/dl.

2.Patients with psychiatric disorders, epilepsy, heart disease, etc

3.Patients with known cases who are immunocompromised like HIV etc; who have haematological disorders such as haemophilia, leukemia etc.

4.Patients with uncontrolled DM, HTN, Hypothyroidism.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of assessment on basis of parameters like- <br/ ><br> <br/ ><br>Artava varna (Colour), Artava pramana, Ruja (Pain), Rajaha sarava avidhi (Duration of menses), tanu, vilambit, vichinna artava. <br/ ><br>Fenil artava <br/ ><br>tanu, vilambit, vichinna artava. <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 1 day and 45 day <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
�CBC <br/ ><br>�Hb% <br/ ><br>�Thyroid profile <br/ ><br>�USG- abdomen and pelvis <br/ ><br>�FSH, LH <br/ ><br>�Serum Estradiol <br/ ><br>�Serum Progesterone <br/ ><br>�Serum Prolactin <br/ ><br>�Serum Testosterone <br/ ><br>�AMH <br/ ><br> <br/ ><br>Timepoint: 1 day and 45 day
© Copyright 2025. All Rights Reserved by MedPath